ive months after drug makers began openly blaming pharmacy benefit managers for rising prices, these crucial middlemen in the arcane and complicated health care system are starting to fight back.

On Monday, the trade group representing pharmacy benefits managers, which negotiate prices on behalf of health plans and create lists of drug that receive preferred coverage, circulated a memo to its members outlining a six-point plan designed to push back against mounting criticism of their business.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • As a pharmvet I can say this is the most unholy alliance since John Looney ran the Rock Island Gang during the Depression.

    -Pharmaceutical Companies
    -In a few cases doctors

    To paraphrase Paul Newman, who played Looney in “The Road to Perdition”. none of them will see heaven.

  • This is outstanding Ed, especially the link to the actual memo!

    Now why is it that there is no similar memo from the PhRMA to its members? At least I am not ware of any. Can you find out please?

    Also, would it be possible for you to interview Express Scripts’ Stephen Miller based on this memo, since he has been very vocal last year?

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy